Biogen Wants Supreme Court To Tackle MS Drug Patent Rights Dispute
This article was originally published in The Pink Sheet Daily
Executive Summary
Patent Trial and Appeal Board ruled against firm regarding proteins for Avonex and Plegridy; Biogen says it should be able to appeal decision to district court.